Literature DB >> 13539792

Phenylbutazone metabolites: antirheumatic, sodium-retaining and uricosuric effects in man.

T F YU, J J BURNS, B C PATON, A B GUTMAN, B B BRODIE.   

Abstract

Entities:  

Keywords:  PHENYLBUTAZONE/in urine; RHEUMATISM; SODIUM/metabolism; URIC ACID/in urine

Mesh：

Substances：

Year:  1958        PMID： 13539792

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN： 0022-3565            Impact factor:   4.030


× No keyword cloud information.
  7 in total

1.  Chronic duodenal obstruction: a mechano-vascular etiology of pancreatitis. II. Experimental observations.

Authors:  A PAULINO-NETTO; D A DREILING
Journal:  Am J Dig Dis       Date:  1960-12

2.  Phenylbutazone and its derivatives with special reference to G.27202.

Authors:  F D HART; D BURLEY
Journal:  Br Med J       Date:  1959-04-25

Review 3.  Pharmacologically active metabolites of drugs and other foreign compounds. Clinical, pharmacological, therapeutic and toxicological considerations.

Authors:  D E Drayer
Journal:  Drugs       Date:  1982-12       Impact factor: 9.546

Review 4.  Pharmacologically active drug metabolites: therapeutic and toxic activities, plasma and urine data in man, accumulation in renal failure.

Authors:  D E Drayer
Journal:  Clin Pharmacokinet       Date:  1976 Nov-Dec       Impact factor: 6.447

5.  Effects of oxyphenbutazone (tandearil) on plasma seromucoids. II. In postoperative inflammation.

Authors:  R BARCELO; C LEBLANC; P RIOPEL; L P LEGRESLEY
Journal:  Can Med Assoc J       Date:  1963-03-23       Impact factor: 8.262

6.  A chronic dose-ranging study of the pharmacokinetics of phenylbutazone in rheumatoid arthritic patients.

Authors:  C Higham; L Aarons; P J Holt; M Lynch; M Rowland
Journal:  Br J Clin Pharmacol       Date:  1981-08       Impact factor: 4.335

Review 7.  Linking Aromatic Hydroxy Metabolic Functionalization of Drug Molecules to Structure and Pharmacologic Activity.

Authors:  Babiker M El-Haj; Samrein B M Ahmed; Mousa A Garawi; Heyam S Ali
Journal:  Molecules       Date:  2018-08-23       Impact factor: 4.411
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.